Floatz logo

Maltodextrin

Mobility

RDC Clinical Pty LtdPhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Mobility cohort.

Asset / SponsorPhaseRating
LEVODOPA
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals
Phase 4BBB
TRIMETHOBENZAMIDE
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals
Phase 4BB
1H-INDOLE-1-CARBOXYLIC ACID, OCTAHYDRO-4-HYDROXY-4-((3-METHYLPHENYL)ETHYNYL)-, METHYL ESTER, (3AR,4S,7AR)-
Novartis Pharmaceuticals
Phase 2BB
APOMORPHINUM
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals
Phase 4BB
Live Combined Bifidobacterium
Beijing Friendship Hospital
Phase 4BB

View all 24 →

Same molecule, other indications

Maltodextrin is also rated in:

Chronic InflammationDormant
BB
Indicative ·
64 / 100
View asset →
Joint PainDormant
BB
Indicative ·
64 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →